Magnusson MO[au] - Search Results

Year	Number of Results
1969	1
1970	1
1971	2
1972	2
1974	5
1975	4
1976	2
1978	1
1980	3
1981	1
1983	2
1984	2
1986	1
1987	1
1989	1
1993	1
1994	1
2004	1
2006	1
2007	1
2008	1
2011	1
2013	1
2017	2
2018	1
2021	2
2022	1

1

Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease.

Schmid U, Weber B, Magnusson MO, Freiwald M. Schmid U, et al. Among authors: magnusson mo. Respir Med. 2021 Apr-May;180:106369. doi: 10.1016/j.rmed.2021.106369. Epub 2021 Mar 14. Respir Med. 2021. PMID: 33798871 Free article.

2

PharmTeX: a LaTeX-Based Open-Source Platform for Automated Reporting Workflow.

Rasmussen CH, Smith MK, Ito K, Sundararajan V, Magnusson MO, Niclas Jonsson E, Fostvedt L, Burger P, McFadyen L, Tensfeldt TG, Nicholas T. Rasmussen CH, et al. Among authors: magnusson mo. AAPS J. 2018 Mar 16;20(3):52. doi: 10.1208/s12248-018-0202-0. AAPS J. 2018. PMID: 29549459

3

Dosing and Switching Strategies for Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Based on Population Pharmacokinetic Modeling and Simulation, and Clinical Trial Data.

Magnusson MO, Samtani MN, Plan EL, Jonsson EN, Rossenu S, Vermeulen A, Russu A. Magnusson MO, et al. CNS Drugs. 2017 Apr;31(4):273-288. doi: 10.1007/s40263-017-0416-1. CNS Drugs. 2017. PMID: 28258365 Review.

4

Vascular complications of renal transplantation.

Palleschi J, Novick AC, Braun WE, Magnusson MO. Palleschi J, et al. Among authors: magnusson mo. Urology. 1980 Jul;16(1):61-7. doi: 10.1016/0090-4295(80)90333-7. Urology. 1980. PMID: 6994326

5

Accuracy of iodine quantification using dual-energy computed tomography with focus on low concentrations.

Ahnfelt A, Dahlman P, Segelsjö M, Magnusson MO, Magnusson A. Ahnfelt A, et al. Among authors: magnusson mo. Acta Radiol. 2022 May;63(5):623-631. doi: 10.1177/02841851211009462. Epub 2021 Apr 22. Acta Radiol. 2022. PMID: 33887965

6

Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia.

Magnusson MO, Samtani MN, Plan EL, Jonsson EN, Rossenu S, Vermeulen A, Russu A. Magnusson MO, et al. Clin Pharmacokinet. 2017 Apr;56(4):421-433. doi: 10.1007/s40262-016-0459-3. Clin Pharmacokinet. 2017. PMID: 27743205 Clinical Trial.

7

Optimal experimental design for assessment of enzyme kinetics in a drug discovery screening environment.

Sjögren E, Nyberg J, Magnusson MO, Lennernäs H, Hooker A, Bredberg U. Sjögren E, et al. Among authors: magnusson mo. Drug Metab Dispos. 2011 May;39(5):858-63. doi: 10.1124/dmd.110.037309. Epub 2011 Feb 2. Drug Metab Dispos. 2011. PMID: 21289074

8

Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairment.

Brennan BJ, Wang K, Blotner S, Magnusson MO, Wilkins JJ, Martin P, Solsky J, Nieforth K, Wat C, Grippo JF. Brennan BJ, et al. Among authors: magnusson mo. Antimicrob Agents Chemother. 2013 Dec;57(12):6097-105. doi: 10.1128/AAC.00608-13. Epub 2013 Sep 30. Antimicrob Agents Chemother. 2013. PMID: 24080649 Free PMC article. Clinical Trial.

9

Effect of heparin modeling on delivered hemodialysis therapy.

Wei SS, Ellis PW, Magnusson MO, Paganini EP. Wei SS, et al. Among authors: magnusson mo. Am J Kidney Dis. 1994 Mar;23(3):389-93. doi: 10.1016/s0272-6386(12)81001-8. Am J Kidney Dis. 1994. PMID: 8128940

10

Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin.

Magnusson MO, Dahl ML, Cederberg J, Karlsson MO, Sandström R. Magnusson MO, et al. Clin Pharmacol Ther. 2008 Jul;84(1):52-62. doi: 10.1038/sj.clpt.6100431. Epub 2007 Oct 31. Clin Pharmacol Ther. 2008. PMID: 17971810

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results